Class IOngoingD-0225-2024
Drug recall · December 6, 2023
Reumo Flex caplets recall
Why: Marketed Without an Approved NDA/ANDA: products found to contain undeclared diclofenac.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Reumo Flex caplets, packaged in 30-count boxes, Manufactured by: Grupo Yepenza de Mexico, SA de CV, Comerciantes 5824 Col Arcos de Guadalupe, Zapopan Jal Mexico, UPC 7 502214 014598
- Lots / codes
All lots, exp 10/20/2024
- Company
- Botanical Be, El Paso, TX
- Distribution
- USA Nationwide
- Initiated
- October 20, 2023 · Voluntary: Firm initiated
- Classified
- January 12, 2024
- Reported
- December 6, 2023
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.